Fat-Suppressed Dynamic and Delayed Gadolinium-Enhanced Volumetric Interpolated Breath-hold Magnetic Resonance Imaging of Cholangiocarcinoma
Authors:
- John R. LeyendeckerJLJohn R. Leyendecker
- Mandip GakhalMGMandip Gakhal
- Khaled M. ElsayesKEKhaled M. Elsayes
- Ronan McDermottRMRonan McDermott
- Vamsidhar R. NarraVNVamsidhar R. Narra
- Jeffrey J. BrownJBJeffrey J. Brown
- 1 March 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
- Vol. 32 (2) , 178-184
Abstract
To determine the enhancement phase providing the highest contrast-to-noise ratio (CNR) between cholangiocarcinoma and liver or portal vein on dynamic and delayed gadolinium-enhanced magnetic resonance imaging (MRI). Precontrast, 3-phase dynamic postcontrast, and delayed postcontrast MRI of the liver was performed in 25 patients with cholangiocarcinoma and correlated with surgical findings, pathology, and other imaging studies. Contrast-to-noise ratios for tumor relative to adjacent liver and portal vein were calculated from signal intensities determined from regions of interest obtained for each phase of enhancement. A subjective assessment of the signal intensity of the periportal tissues relative to the portal vein was made for each set of delayed images. A mass was visible in 24 of 25 patients. Tumor masses were hypointense in 92%, 67%, 75%, and 21%; isointense in 8%, 8%, 17%, and 12%; and hyperintense in 0%, 25%, 8%, and 67% of patients relative to liver on precontrast, arterial, portal venous, and delayed images, respectively. No single phase of gadolinium enhancement demonstrated consistently superior tumor-versus-liver CNR. Delayed imaging demonstrated the highest tumor-versus-liver CNR in 25% of patients and the lowest in 33%. The portal venous phase demonstrated the highest tumor-versus-portal vein CNR in 75% of patients. Delayed postcontrast images demonstrated the lowest tumor-versus-portal vein CNR in 38% of patients. Periportal tissues were isointense to portal vein in all but 1 patient on delayed images. No single phase of dynamic and delayed gadolinium-enhanced MRI demonstrates superior CNR between cholangiocarcinoma and normally enhancing liver, although the portal phase provides the best CNR between tumor and portal vein in most cases. Although delayed enhancement is typical of cholangiocarcinoma, delayed imaging does not necessarily offer superior contrast between tumor and liver parenchyma compared with other phases of enhancement. Differentiation between tumor and portal vein and periportal tissues may be difficult on delayed images.Keywords
This publication has 32 references indexed in Scilit:
- Improved operative and survival outcomes of surgical treatment for hilar cholangiocarcinomaBritish Journal of Surgery, 2006
- What Is the Current State-of-the-Art Imaging for Detection and Staging of Cholangiocarcinoma?The Oncologist, 2006
- Hepatic Resection in the Treatment of Hilar CholangiocarcinomaAdvances in Surgery, 2006
- Staging, Resectability, and Outcome in 225 Patients With Hilar CholangiocarcinomaAnnals of Surgery, 2001
- Changing strategies in diagnosis and management of hilar cholangiocarcinomaLiver Transplantation, 2000
- Aggressive Surgical Treatment of Intrahepatic Cholangiocarcinoma: Predictors of OutcomesJournal of the American College of Surgeons, 1998
- Malignant hepatic hilar tumors: can ultrasonography be used as an alternative to angiography with CT arterial portography for determination of resectability?Journal of Ultrasound in Medicine, 1996
- Improvements in Survival by Aggressive Resections of Hilar CholangiocarcinomaAnnals of Surgery, 1993
- Staging of hilar cholangiocarcinoma by ultrasound and duplex sonography: a comparison with angiography and operative findingsBritish Journal of Radiology, 1992
- Hilar cholangiocarcinoma: comparative study with sonography and CT.Radiology, 1989